PharmaRoth Labs (PharmaRoth Labs) Debt-to-Equity : 0.00 (As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Debt-to-Equity?

PharmaRoth Labs's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2011 was $0.00 Mil. PharmaRoth Labs's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2011 was $0.00 Mil. PharmaRoth Labs's Total Stockholders Equity for the quarter that ended in Mar. 2011 was $-0.30 Mil. PharmaRoth Labs's debt to equity for the quarter that ended in Mar. 2011 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for PharmaRoth Labs's Debt-to-Equity or its related term are showing as below:

ROTH's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.15
* Ranked among companies with meaningful Debt-to-Equity only.

PharmaRoth Labs Debt-to-Equity Historical Data

The historical data trend for PharmaRoth Labs's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Debt-to-Equity Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Debt-to-Equity

-0.86

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Debt-to-Equity	Get a 7-Day Free Trial											-	-0.86	-	-0.78	-

Competitive Comparison of PharmaRoth Labs's Debt-to-Equity

For the Biotechnology subindustry, PharmaRoth Labs's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaRoth Labs's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's Debt-to-Equity falls into.

PharmaRoth Labs Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

PharmaRoth Labs's Debt to Equity Ratio for the fiscal year that ended in Jun. 2010 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.25)	/	-0.292
	=	-0.86

PharmaRoth Labs's Debt to Equity Ratio for the quarter that ended in Mar. 2011 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-0.295
	=	0.00

PharmaRoth Labs (GREY:ROTH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

PharmaRoth Labs Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022